kaiser cover tirzepatide (weight loss) 15 mg/0.5 mL subcutaneous pen injector Eli Lilly said Kaiser (GA)

Grateful for the opportunity to go on CBS Mornings today to discuss issues with helping patients find access to care now that shortages are over and they cannot rely on compounding

1 Dose strength Rybelsus: lowmoderate daily doses for glucose control Oral Wegovy: much higher daily dose to match injectable Wegovy exposure With oral bioavailability at ~1%, obesity efficacy simply requires more drug not interchangeable

Natural metabolic support alternatives for injection-averse consumers

Variety and Flavor: Savor a delicious assortment of keto-friendly meals packed with flavor and nutrients

Mean diabetes duration was 2.5 years